Slone Partners’ 2018 PMC Interview Series includes an exclusive, in-depth interview with William Dalton Ph.D., M.D., the Founder and Executive Chair of M2GEN, a health informatics solutions company. Focused on accelerating the discovery, development, and delivery of personalized medicine, M2GEN was founded in 2006 at the Moffitt Cancer Center to operationalize the Total Cancer Care® Protocol, and through its proprietary ORIEN AVATAR™ solution, to partner with cancer research centers via The Oncology Research Information Exchange Network (ORIEN). Together, M2GEN works with biopharmaceutical companies to address the most challenging questions in drug development. Dr. Dalton discusses personalized medicine, his leadership tenure as CEO, and the importance of sharing information with the largest pharmaceutical companies in the world. This ongoing series of healthcare executive discussions is presented in partnership with Personalized Medicine Coalition.